Exclusive: FloraWorks Completes $2.25M Series-A Financing For Cannabinoid Research
FloraWorks, a cannabinoid therapeutics company specializing in rare and novel cannabinoids, has successfully completed a $2.25 million Series-A financing round. Leading this significant investment was life sciences venture capital firm, Bonaventure Equity LLC.
